Metabolic Disorders & Obesity

The intricate relationship between metabolic disorders & obesity plays a pivotal role in diabetes pathogenesis. Excess adiposity, particularly visceral fat accumulation, promotes insulin resistance and chronic inflammation, increasing the likelihood of type 2 diabetes. Dysregulated lipid metabolism and hormonal imbalances further exacerbate metabolic dysfunction, contributing to conditions such as metabolic syndrome and non-alcoholic fatty liver disease. Emerging research highlights the role of gut microbiota and genetic predisposition in metabolic health. Novel therapeutic strategies, including GLP-1 receptor agonists, bariatric surgery, and personalized nutrition plans, are proving effective in managing obesity-driven metabolic disorders. A multidisciplinary approach integrating pharmacotherapy, lifestyle interventions, and early screening is essential for preventing disease progression.

Committee Members
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - Wan Rosli Wan Ishak

Wan Rosli Wan Ishak

Universiti Sains Malaysia, Malaysia
Diabetes 2026 Speakers
Speaker at Diabetes  2026 - Mahir Khalil Ibrahim Jallo

Mahir Khalil Ibrahim Jallo

Gulf Medical University, Canada
Speaker at Diabetes  2026 - F Buck Willis

F Buck Willis

Christian College of Medicine, Belize
Speaker at Diabetes  2026 - Anil Harrison

Anil Harrison

Midwestern University, United States
Speaker at Diabetes  2026 - David Navazio

David Navazio

Gentell, United States
Speaker at Diabetes  2026 - Sujith Rajan

Sujith Rajan

NYU Long Island School of Medicine, United States
Speaker at Diabetes  2026 - David Petch

David Petch

utR Biotech, Canada
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp